2024 annual financial data
Cartesian Therapeutics 2024 Operating margin
Cartesian Therapeutics 2024 operating margin with verified reported values.
Direct answer
Operating margin was -112.81%.
Operating income was -43,897,000 USD and net income was -77,424,000 USD.
Operating cash flow was -23,674,000 USD.
Get free Cartesian Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 38,913,000 USD
- Operating income
- -43,897,000 USD
- Net income
- -77,424,000 USD
- Operating cash flow
- -23,674,000 USD